Microsoft has laid out an ambitious plan to develop its own AI superintelligence as it moves to separate its artificial intelligence plans from those of OpenAI, the startup it has financed to the tune of $13 billion, an investment valued at $135 billion following OpenAI’s restructuring as a for-profit public benefit company structure. Microsoft has reorganized to concentrate internal AI efforts under a unit called the MAI Superintelligence Team led by group CEO Mustafa Suleyman. MAI will work towards “Humanist Superintelligence (HSI): incredibly advanced AI capabilities that always work for, in service of, people and humanity more generally,” Suleyman says.

In a blog post, Suleyman writes that Microsoft HSI will be superintelligence with safety guardrails and human overseers. “We want to both explore and prioritize how the most advanced forms of AI can keep humanity in control while at the same time accelerating our path towards tackling our most pressing global challenges,” Suleyman explains.

The post goes on to list three primary objectives. “Microsoft’s first goal is to develop better AI assistants for consumers” with an emphasis on affordability and personalization, reports SiliconANGLE, writing that the personalization features will, among other things, offer “the ability to generate highly customized learning materials.”

The second goal is “medial superintelligence,” an AI that can deliver “expert level performance at the full range of diagnostics, alongside highly capable planning and prediction in operational clinical settings.”

The third area of focus is renewable energy and carbon-negative materials. Suleyman notes that these are only some of the things his division will strive for.

Microsoft has already made progress in AI-powered medical research. “In June, the company debuted an AI system called MAI-DxO that is optimized to tackle The New England Journal of Medicine Case Challenges,” described as “lists of symptoms that readers are asked to diagnose,” according to SiliconANGLE.

While human doctors have had about a 20 percent success rate in identifying the root causes of the symptoms, “MAI-DxO achieved a 85 percent score in a benchmark test,” SiliconANGLE adds.

“Though still close partners, Microsoft and OpenAI now compete in a number of ways,” reports The Wall Street Journal, recapping how last month Microsoft updated its contract with OpenAI, and now has “a 27 percent stake in the startup’s new public-benefit corporation” and “access to OpenAI’s models until 2032, a schedule Suleyman said gives his team time to make its models into leading technology.”

Related:
Microsoft Forms Superintelligence Team Under AI Chief Suleyman ‘to Serve Humanity’, CNBC, 11/6/25
Microsoft Forms Superintelligence Team to Rival Meta’s, Stresses ‘Humanist’ Focus, Business Insider, 11/6/25